MovDisordV3, Main, Exploration, bibRecord, 005275

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor

Identifieur interne : 005275 ( Main/Exploration ); précédent : 005274; suivant : 005276

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor

Auteurs : Jörg Wissel [Allemagne, Autriche] ; Florian Masuhr [Allemagne] ; Ludwig Schelosky [Allemagne] ; Georg Ebersbach [Allemagne, Autriche] ; Werner Poewe [Autriche]

Source :

Movement Disorders [ 0885-3185 ] ; 1997-09.

RBID : ISTEX:C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8

Descripteurs français

Pascal (Inist)
- Chimiothérapie, Clostridium botulinum, Homme, Toxine, Traitement, Tremblement, Tête, Voie intramusculaire.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adult, Aged, Aged, 80 and over, Anti-Dyskinesia Agents (therapeutic use), Botulinum Toxins, Type A (therapeutic use), Botulinum toxin, Cervical dystonia, Chemotherapy, Clostridium botulinum, Cross-Sectional Studies, Dystonia (complications), Dystonia (drug therapy), Electromyography, Essential tremor, Female, Head, Head Movements (drug effects), Head tremor, Human, Humans, Intramuscular administration, Male, Middle Aged, Neck Muscles (drug effects), Neck Muscles (physiopathology), Oscillometry, Pain (drug therapy), Prospective Studies, Toxin, Treatment, Treatment Outcome, Tremor, Tremor (drug therapy), Tremor (etiology).
MESH :
- chemical , therapeutic use : Anti-Dyskinesia Agents, Botulinum Toxins, Type A.
- complications : Dystonia.
- drug effects : Head Movements, Neck Muscles.
- drug therapy : Dystonia, Pain, Tremor.
- etiology : Tremor.
- physiopathology : Neck Muscles.
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Electromyography, Female, Humans, Male, Middle Aged, Oscillometry, Prospective Studies, Treatment Outcome.

Abstract

We treated 43 patients who had head tremor as the major complaint with local botulinum toxin type A (Btx A) injections into neck muscles: 29 patients were classified as suffering from tremulous cervical dystonia (TCD), and 14 had head tremor without dystonia (HT). All patients were clinically assessed by means of the Tsui scale and a 4‐point pain scale at baseline and follow‐up visit. Quantitative recordings of head tremor with a bidirectional accelerometer system (horizontal and vertical planes) placed on the forehead were obtained before and 2–3 weeks after Btx A injections. Muscle selection for an injection was based on the visible and palpable tremor oscillation in the involved neck muscles and on analysis of standardized simultaneous electromyographic recordings of six cervical muscles. Patients with HT recieved mean total doses of 400 units (U) of Dysport (Btx A) (range, 160–560 U) distributed between the two splenius capitis muscles. Patients with TCD received a mean total dose of 500 U Dysport (range, 320–720 U) injected into a mean of 3 muscles (range, 2–4 muscles). The condition of all patients with HT and of 26 of the 29 patients with TCD improved subjectively. The total on the Tsui scale as well as pain scores decreased significantly (p < 0.05) following treatment. Latency of onset, duration of improvement, and side effects showed no significant difference in HT and TCD. Amplitude of HT decreased significantly for both groups following treatment. The mean dominant peak frequency in TCD and HT was slightly less than 5 Hz and did not change significantly after treatment.

Url:

https://api.istex.fr/document/C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8/fulltext/pdf

DOI: 10.1002/mds.870120516

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor</title>
<author><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
</author>
<author><name sortKey="Masuhr, Florian" sort="Masuhr, Florian" uniqKey="Masuhr F" first="Florian" last="Masuhr">Florian Masuhr</name>
</author>
<author><name sortKey="Schelosky, Ludwig" sort="Schelosky, Ludwig" uniqKey="Schelosky L" first="Ludwig" last="Schelosky">Ludwig Schelosky</name>
</author>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><country>Autriche</country>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120516</idno>
<idno type="url">https://api.istex.fr/document/C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002101</idno>
<idno type="wicri:Area/Istex/Curation">002101</idno>
<idno type="wicri:Area/Istex/Checkpoint">003898</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Wissel J:quantitative:assessment:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9380055</idno>
<idno type="wicri:Area/PubMed/Corpus">004601</idno>
<idno type="wicri:Area/PubMed/Curation">004601</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004590</idno>
<idno type="wicri:Area/Ncbi/Merge">004D82</idno>
<idno type="wicri:Area/Ncbi/Curation">004D82</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D82</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Wissel J:quantitative:assessment:of</idno>
<idno type="wicri:Area/Main/Merge">008303</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:97-0489609</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003184</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003640</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003166</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Wissel J:quantitative:assessment:of</idno>
<idno type="wicri:Area/Main/Merge">008521</idno>
<idno type="wicri:Area/Main/Curation">005275</idno>
<idno type="wicri:Area/Main/Exploration">005275</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor</title>
<author><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Virchow Clinic, Charité, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Masuhr, Florian" sort="Masuhr, Florian" uniqKey="Masuhr F" first="Florian" last="Masuhr">Florian Masuhr</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Virchow Clinic, Charité, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schelosky, Ludwig" sort="Schelosky, Ludwig" uniqKey="Schelosky L" first="Ludwig" last="Schelosky">Ludwig Schelosky</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Virchow Clinic, Charité, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Virchow Clinic, Charité, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-09">1997-09</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="722">722</biblScope>
<biblScope unit="page" to="726">726</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8</idno>
<idno type="DOI">10.1002/mds.870120516</idno>
<idno type="ArticleID">MDS870120516</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Botulinum toxin</term>
<term>Cervical dystonia</term>
<term>Chemotherapy</term>
<term>Clostridium botulinum</term>
<term>Cross-Sectional Studies</term>
<term>Dystonia (complications)</term>
<term>Dystonia (drug therapy)</term>
<term>Electromyography</term>
<term>Essential tremor</term>
<term>Female</term>
<term>Head</term>
<term>Head Movements (drug effects)</term>
<term>Head tremor</term>
<term>Human</term>
<term>Humans</term>
<term>Intramuscular administration</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neck Muscles (drug effects)</term>
<term>Neck Muscles (physiopathology)</term>
<term>Oscillometry</term>
<term>Pain (drug therapy)</term>
<term>Prospective Studies</term>
<term>Toxin</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
<term>Tremor</term>
<term>Tremor (drug therapy)</term>
<term>Tremor (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Head Movements</term>
<term>Neck Muscles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia</term>
<term>Pain</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Neck Muscles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cross-Sectional Studies</term>
<term>Electromyography</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Oscillometry</term>
<term>Prospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Chimiothérapie</term>
<term>Clostridium botulinum</term>
<term>Homme</term>
<term>Toxine</term>
<term>Traitement</term>
<term>Tremblement</term>
<term>Tête</term>
<term>Voie intramusculaire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We treated 43 patients who had head tremor as the major complaint with local botulinum toxin type A (Btx A) injections into neck muscles: 29 patients were classified as suffering from tremulous cervical dystonia (TCD), and 14 had head tremor without dystonia (HT). All patients were clinically assessed by means of the Tsui scale and a 4‐point pain scale at baseline and follow‐up visit. Quantitative recordings of head tremor with a bidirectional accelerometer system (horizontal and vertical planes) placed on the forehead were obtained before and 2–3 weeks after Btx A injections. Muscle selection for an injection was based on the visible and palpable tremor oscillation in the involved neck muscles and on analysis of standardized simultaneous electromyographic recordings of six cervical muscles. Patients with HT recieved mean total doses of 400 units (U) of Dysport (Btx A) (range, 160–560 U) distributed between the two splenius capitis muscles. Patients with TCD received a mean total dose of 500 U Dysport (range, 320–720 U) injected into a mean of 3 muscles (range, 2–4 muscles). The condition of all patients with HT and of 26 of the 29 patients with TCD improved subjectively. The total on the Tsui scale as well as pain scores decreased significantly (p < 0.05) following treatment. Latency of onset, duration of improvement, and side effects showed no significant difference in HT and TCD. Amplitude of HT decreased significantly for both groups following treatment. The mean dominant peak frequency in TCD and HT was slightly less than 5 Hz and did not change significantly after treatment.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Autriche</li>
</country>
<region><li>Berlin</li>
<li>Tyrol (Land)</li>
</region>
<settlement><li>Berlin</li>
<li>Innsbruck</li>
</settlement>
<orgName><li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree><country name="Allemagne"><region name="Berlin"><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
</region>
<name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<name sortKey="Masuhr, Florian" sort="Masuhr, Florian" uniqKey="Masuhr F" first="Florian" last="Masuhr">Florian Masuhr</name>
<name sortKey="Schelosky, Ludwig" sort="Schelosky, Ludwig" uniqKey="Schelosky L" first="Ludwig" last="Schelosky">Ludwig Schelosky</name>
</country>
<country name="Autriche"><noRegion><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
</noRegion>
<name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005275 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005275 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C5CABB120F7762DE0B7621DEC36BC76AF8EA3CF8
   |texte=   Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.